Review





Similar Products

86
Technical Manufacturing Company poly d l lactic acid pdla
Poly D L Lactic Acid Pdla, supplied by Technical Manufacturing Company, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/poly d l lactic acid pdla/product/Technical Manufacturing Company
Average 86 stars, based on 1 article reviews
poly d l lactic acid pdla - by Bioz Stars, 2025-06
86/100 stars
  Buy from Supplier

86
Millipore poly d l lactic acid polyethylene glycol n hydroxysuccinimide
Poly D L Lactic Acid Polyethylene Glycol N Hydroxysuccinimide, supplied by Millipore, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/poly d l lactic acid polyethylene glycol n hydroxysuccinimide/product/Millipore
Average 86 stars, based on 1 article reviews
poly d l lactic acid polyethylene glycol n hydroxysuccinimide - by Bioz Stars, 2025-06
86/100 stars
  Buy from Supplier

86
Millipore poly d l lactic co glycolic acid plga
<t>PLGA-PEI-si-m/hVDAC1-B</t> treatment of urethane-induced lung cancer reduced tumor size and number. ( A ) Schematic illustration of the study design: A/J mice, 7–8 weeks old, were injected i.p. with urethane (1 mg/gr body weight), and tumor development and treatment are indicated. ( B ) Photo of lungs from mice sacrificed at week 19, after exposure to urethane, with the arrows pointing to tumors. Following tracking of tumor development with MRI at week 18, treatment with PLGA-PEI-si-m/hVDAC1 or PLGA-PEI-si-NT (200 nM blood concentration) was started at week 19, and performed three times a week until the mice were sacrificed at week 38. ( C , F ) Representative H&E staining of paraffin-embedded, formaldehyde-fixed sections of the lungs after treatment with PLGA-PEI-si-m/hVDAC1-B or PLGA-PEI-si-NT. ( D , E ) Quantitative analysis of tumor area presented as a % of the total section area (PLGA-PEI-si-NT, n = 7, PLGA-PEI-si-m/hVDAC1, n = 8) ( D ), and the number of tumors (PLGA-PEI-si-NT n = 4 and PLGA-PEI-si-m/hVDAC1-B, n = 4) ( E ). Results reflect the mean ± SEM, *** p ≤ 0.001. ( F ) Enlargement of a selected area from the lung shown in C.
Poly D L Lactic Co Glycolic Acid Plga, supplied by Millipore, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/poly d l lactic co glycolic acid plga/product/Millipore
Average 86 stars, based on 1 article reviews
poly d l lactic co glycolic acid plga - by Bioz Stars, 2025-06
86/100 stars
  Buy from Supplier

86
Millipore poly d l lactic co glycolic acid ho plga cooh
<t>PLGA-PEI-si-m/hVDAC1-B</t> treatment of urethane-induced lung cancer reduced tumor size and number. ( A ) Schematic illustration of the study design: A/J mice, 7–8 weeks old, were injected i.p. with urethane (1 mg/gr body weight), and tumor development and treatment are indicated. ( B ) Photo of lungs from mice sacrificed at week 19, after exposure to urethane, with the arrows pointing to tumors. Following tracking of tumor development with MRI at week 18, treatment with PLGA-PEI-si-m/hVDAC1 or PLGA-PEI-si-NT (200 nM blood concentration) was started at week 19, and performed three times a week until the mice were sacrificed at week 38. ( C , F ) Representative H&E staining of paraffin-embedded, formaldehyde-fixed sections of the lungs after treatment with PLGA-PEI-si-m/hVDAC1-B or PLGA-PEI-si-NT. ( D , E ) Quantitative analysis of tumor area presented as a % of the total section area (PLGA-PEI-si-NT, n = 7, PLGA-PEI-si-m/hVDAC1, n = 8) ( D ), and the number of tumors (PLGA-PEI-si-NT n = 4 and PLGA-PEI-si-m/hVDAC1-B, n = 4) ( E ). Results reflect the mean ± SEM, *** p ≤ 0.001. ( F ) Enlargement of a selected area from the lung shown in C.
Poly D L Lactic Co Glycolic Acid Ho Plga Cooh, supplied by Millipore, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/poly d l lactic co glycolic acid ho plga cooh/product/Millipore
Average 86 stars, based on 1 article reviews
poly d l lactic co glycolic acid ho plga cooh - by Bioz Stars, 2025-06
86/100 stars
  Buy from Supplier

86
Millipore pdla poly d l lactic acid 15 000 g ml sigma aldrich
<t>PLGA-PEI-si-m/hVDAC1-B</t> treatment of urethane-induced lung cancer reduced tumor size and number. ( A ) Schematic illustration of the study design: A/J mice, 7–8 weeks old, were injected i.p. with urethane (1 mg/gr body weight), and tumor development and treatment are indicated. ( B ) Photo of lungs from mice sacrificed at week 19, after exposure to urethane, with the arrows pointing to tumors. Following tracking of tumor development with MRI at week 18, treatment with PLGA-PEI-si-m/hVDAC1 or PLGA-PEI-si-NT (200 nM blood concentration) was started at week 19, and performed three times a week until the mice were sacrificed at week 38. ( C , F ) Representative H&E staining of paraffin-embedded, formaldehyde-fixed sections of the lungs after treatment with PLGA-PEI-si-m/hVDAC1-B or PLGA-PEI-si-NT. ( D , E ) Quantitative analysis of tumor area presented as a % of the total section area (PLGA-PEI-si-NT, n = 7, PLGA-PEI-si-m/hVDAC1, n = 8) ( D ), and the number of tumors (PLGA-PEI-si-NT n = 4 and PLGA-PEI-si-m/hVDAC1-B, n = 4) ( E ). Results reflect the mean ± SEM, *** p ≤ 0.001. ( F ) Enlargement of a selected area from the lung shown in C.
Pdla Poly D L Lactic Acid 15 000 G Ml Sigma Aldrich, supplied by Millipore, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pdla poly d l lactic acid 15 000 g ml sigma aldrich/product/Millipore
Average 86 stars, based on 1 article reviews
pdla poly d l lactic acid 15 000 g ml sigma aldrich - by Bioz Stars, 2025-06
86/100 stars
  Buy from Supplier

86
Tokyo Chemical Industry biodegradable poly d l lactic acid
<t>PLGA-PEI-si-m/hVDAC1-B</t> treatment of urethane-induced lung cancer reduced tumor size and number. ( A ) Schematic illustration of the study design: A/J mice, 7–8 weeks old, were injected i.p. with urethane (1 mg/gr body weight), and tumor development and treatment are indicated. ( B ) Photo of lungs from mice sacrificed at week 19, after exposure to urethane, with the arrows pointing to tumors. Following tracking of tumor development with MRI at week 18, treatment with PLGA-PEI-si-m/hVDAC1 or PLGA-PEI-si-NT (200 nM blood concentration) was started at week 19, and performed three times a week until the mice were sacrificed at week 38. ( C , F ) Representative H&E staining of paraffin-embedded, formaldehyde-fixed sections of the lungs after treatment with PLGA-PEI-si-m/hVDAC1-B or PLGA-PEI-si-NT. ( D , E ) Quantitative analysis of tumor area presented as a % of the total section area (PLGA-PEI-si-NT, n = 7, PLGA-PEI-si-m/hVDAC1, n = 8) ( D ), and the number of tumors (PLGA-PEI-si-NT n = 4 and PLGA-PEI-si-m/hVDAC1-B, n = 4) ( E ). Results reflect the mean ± SEM, *** p ≤ 0.001. ( F ) Enlargement of a selected area from the lung shown in C.
Biodegradable Poly D L Lactic Acid, supplied by Tokyo Chemical Industry, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/biodegradable poly d l lactic acid/product/Tokyo Chemical Industry
Average 86 stars, based on 1 article reviews
biodegradable poly d l lactic acid - by Bioz Stars, 2025-06
86/100 stars
  Buy from Supplier

86
Macklin Inc poly d l lactic co glycolic acid
<t>PLGA-PEI-si-m/hVDAC1-B</t> treatment of urethane-induced lung cancer reduced tumor size and number. ( A ) Schematic illustration of the study design: A/J mice, 7–8 weeks old, were injected i.p. with urethane (1 mg/gr body weight), and tumor development and treatment are indicated. ( B ) Photo of lungs from mice sacrificed at week 19, after exposure to urethane, with the arrows pointing to tumors. Following tracking of tumor development with MRI at week 18, treatment with PLGA-PEI-si-m/hVDAC1 or PLGA-PEI-si-NT (200 nM blood concentration) was started at week 19, and performed three times a week until the mice were sacrificed at week 38. ( C , F ) Representative H&E staining of paraffin-embedded, formaldehyde-fixed sections of the lungs after treatment with PLGA-PEI-si-m/hVDAC1-B or PLGA-PEI-si-NT. ( D , E ) Quantitative analysis of tumor area presented as a % of the total section area (PLGA-PEI-si-NT, n = 7, PLGA-PEI-si-m/hVDAC1, n = 8) ( D ), and the number of tumors (PLGA-PEI-si-NT n = 4 and PLGA-PEI-si-m/hVDAC1-B, n = 4) ( E ). Results reflect the mean ± SEM, *** p ≤ 0.001. ( F ) Enlargement of a selected area from the lung shown in C.
Poly D L Lactic Co Glycolic Acid, supplied by Macklin Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/poly d l lactic co glycolic acid/product/Macklin Inc
Average 86 stars, based on 1 article reviews
poly d l lactic co glycolic acid - by Bioz Stars, 2025-06
86/100 stars
  Buy from Supplier

86
Evonik poly d l lactic acid pla
<t>PLGA-PEI-si-m/hVDAC1-B</t> treatment of urethane-induced lung cancer reduced tumor size and number. ( A ) Schematic illustration of the study design: A/J mice, 7–8 weeks old, were injected i.p. with urethane (1 mg/gr body weight), and tumor development and treatment are indicated. ( B ) Photo of lungs from mice sacrificed at week 19, after exposure to urethane, with the arrows pointing to tumors. Following tracking of tumor development with MRI at week 18, treatment with PLGA-PEI-si-m/hVDAC1 or PLGA-PEI-si-NT (200 nM blood concentration) was started at week 19, and performed three times a week until the mice were sacrificed at week 38. ( C , F ) Representative H&E staining of paraffin-embedded, formaldehyde-fixed sections of the lungs after treatment with PLGA-PEI-si-m/hVDAC1-B or PLGA-PEI-si-NT. ( D , E ) Quantitative analysis of tumor area presented as a % of the total section area (PLGA-PEI-si-NT, n = 7, PLGA-PEI-si-m/hVDAC1, n = 8) ( D ), and the number of tumors (PLGA-PEI-si-NT n = 4 and PLGA-PEI-si-m/hVDAC1-B, n = 4) ( E ). Results reflect the mean ± SEM, *** p ≤ 0.001. ( F ) Enlargement of a selected area from the lung shown in C.
Poly D L Lactic Acid Pla, supplied by Evonik, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/poly d l lactic acid pla/product/Evonik
Average 86 stars, based on 1 article reviews
poly d l lactic acid pla - by Bioz Stars, 2025-06
86/100 stars
  Buy from Supplier

86
Akina Inc poly d l lactic co glycolic acid plga
<t>PLGA-PEI-si-m/hVDAC1-B</t> treatment of urethane-induced lung cancer reduced tumor size and number. ( A ) Schematic illustration of the study design: A/J mice, 7–8 weeks old, were injected i.p. with urethane (1 mg/gr body weight), and tumor development and treatment are indicated. ( B ) Photo of lungs from mice sacrificed at week 19, after exposure to urethane, with the arrows pointing to tumors. Following tracking of tumor development with MRI at week 18, treatment with PLGA-PEI-si-m/hVDAC1 or PLGA-PEI-si-NT (200 nM blood concentration) was started at week 19, and performed three times a week until the mice were sacrificed at week 38. ( C , F ) Representative H&E staining of paraffin-embedded, formaldehyde-fixed sections of the lungs after treatment with PLGA-PEI-si-m/hVDAC1-B or PLGA-PEI-si-NT. ( D , E ) Quantitative analysis of tumor area presented as a % of the total section area (PLGA-PEI-si-NT, n = 7, PLGA-PEI-si-m/hVDAC1, n = 8) ( D ), and the number of tumors (PLGA-PEI-si-NT n = 4 and PLGA-PEI-si-m/hVDAC1-B, n = 4) ( E ). Results reflect the mean ± SEM, *** p ≤ 0.001. ( F ) Enlargement of a selected area from the lung shown in C.
Poly D L Lactic Co Glycolic Acid Plga, supplied by Akina Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/poly d l lactic co glycolic acid plga/product/Akina Inc
Average 86 stars, based on 1 article reviews
poly d l lactic co glycolic acid plga - by Bioz Stars, 2025-06
86/100 stars
  Buy from Supplier

Image Search Results


PLGA-PEI-si-m/hVDAC1-B treatment of urethane-induced lung cancer reduced tumor size and number. ( A ) Schematic illustration of the study design: A/J mice, 7–8 weeks old, were injected i.p. with urethane (1 mg/gr body weight), and tumor development and treatment are indicated. ( B ) Photo of lungs from mice sacrificed at week 19, after exposure to urethane, with the arrows pointing to tumors. Following tracking of tumor development with MRI at week 18, treatment with PLGA-PEI-si-m/hVDAC1 or PLGA-PEI-si-NT (200 nM blood concentration) was started at week 19, and performed three times a week until the mice were sacrificed at week 38. ( C , F ) Representative H&E staining of paraffin-embedded, formaldehyde-fixed sections of the lungs after treatment with PLGA-PEI-si-m/hVDAC1-B or PLGA-PEI-si-NT. ( D , E ) Quantitative analysis of tumor area presented as a % of the total section area (PLGA-PEI-si-NT, n = 7, PLGA-PEI-si-m/hVDAC1, n = 8) ( D ), and the number of tumors (PLGA-PEI-si-NT n = 4 and PLGA-PEI-si-m/hVDAC1-B, n = 4) ( E ). Results reflect the mean ± SEM, *** p ≤ 0.001. ( F ) Enlargement of a selected area from the lung shown in C.

Journal: Cancers

Article Title: Mitochondrial VDAC1 Silencing in Urethane-Induced Lung Cancer Inhibits Tumor Growth and Alters Cancer Oncogenic Properties

doi: 10.3390/cancers16172970

Figure Lengend Snippet: PLGA-PEI-si-m/hVDAC1-B treatment of urethane-induced lung cancer reduced tumor size and number. ( A ) Schematic illustration of the study design: A/J mice, 7–8 weeks old, were injected i.p. with urethane (1 mg/gr body weight), and tumor development and treatment are indicated. ( B ) Photo of lungs from mice sacrificed at week 19, after exposure to urethane, with the arrows pointing to tumors. Following tracking of tumor development with MRI at week 18, treatment with PLGA-PEI-si-m/hVDAC1 or PLGA-PEI-si-NT (200 nM blood concentration) was started at week 19, and performed three times a week until the mice were sacrificed at week 38. ( C , F ) Representative H&E staining of paraffin-embedded, formaldehyde-fixed sections of the lungs after treatment with PLGA-PEI-si-m/hVDAC1-B or PLGA-PEI-si-NT. ( D , E ) Quantitative analysis of tumor area presented as a % of the total section area (PLGA-PEI-si-NT, n = 7, PLGA-PEI-si-m/hVDAC1, n = 8) ( D ), and the number of tumors (PLGA-PEI-si-NT n = 4 and PLGA-PEI-si-m/hVDAC1-B, n = 4) ( E ). Results reflect the mean ± SEM, *** p ≤ 0.001. ( F ) Enlargement of a selected area from the lung shown in C.

Article Snippet: Bovine serum albumin (BSA), poly (D, L-lactic-co-glycolic acid) (PLGA), polyethylenimine (PEI), polyvinyl alcohol (PVA), trypan blue, Triton X-100, Tween-20, hematoxylin, eosin, 4′,6-diamidino-2-phenylindole (DAPI), dimethyl sulfoxide (DMSO), and urethane were obtained from Sigma-Aldrich (St. Louis, MO, USA).

Techniques: Injection, Concentration Assay, Staining

PLGA-PEI-si-m/hVDAC1-B treatment of urethane-induced lung cancer decreased VDAC1 expression level and inhibited tumor growth. ( A ) Schematic illustration of the study design: A/J mice, 7–8 weeks old, were injected i.p. with urethane (1 mg/gr body weight). Treatment with PLGA-PEI-si-m/hVDAC1 or PLGA-PEI-si-NT (350 nM) was started at week 21 (group A) or at week 23 (group B) and continued three times a week until the mice were sacrificed. MRI imaging was performed at weeks 18, 30, 32, and 33. Mice were sacrificed at week 33 (group A) and week 32 (group B). ( B ) Representative MRI images at week 33 (group A) of PLGA-PEI-si-NT- and PLGA-PEI-si-m/hVDAC1-B-treated mice. The arrows point to tumors. ( C ) Quantification of tumor volume from MRI images of group A at week 30 (PLGA-PEI-si-NT, n = 6, PLGA-PEI-si-m/hVDAC1-B, n = 7) and week 33 (PLGA-PEI-si-NT, n = 5, PLGA-PEI-si-m/hVDAC1-B, n = 5) and for group B at week 32 (PLGA-PEI-si-NT, n = 3, PLGA-PEI-si-m/hVDAC1-B, n = 4). ( D ) IF staining of VDAC1 in lung sections from PLGA-PEI-si-m/hVDAC1-B and PLGA-PEI-si-NT-treated mice. The squares point to the area enlarged below. ( E , F ) IHC staining for KI-67 using specific antibodies of PLGA-PEI-si-NT- and PLGA-PEI-si-m/hVDAC1-B-treated mice ( E ). For the sections, the lungs with tumors are shown with enlarged area below. KI-67 staining intensity was analyzed quantitatively (n = 7) ( F ). Results present the mean ± SEM, * p ≤ 0.05, *** p ≤ 0.001.

Journal: Cancers

Article Title: Mitochondrial VDAC1 Silencing in Urethane-Induced Lung Cancer Inhibits Tumor Growth and Alters Cancer Oncogenic Properties

doi: 10.3390/cancers16172970

Figure Lengend Snippet: PLGA-PEI-si-m/hVDAC1-B treatment of urethane-induced lung cancer decreased VDAC1 expression level and inhibited tumor growth. ( A ) Schematic illustration of the study design: A/J mice, 7–8 weeks old, were injected i.p. with urethane (1 mg/gr body weight). Treatment with PLGA-PEI-si-m/hVDAC1 or PLGA-PEI-si-NT (350 nM) was started at week 21 (group A) or at week 23 (group B) and continued three times a week until the mice were sacrificed. MRI imaging was performed at weeks 18, 30, 32, and 33. Mice were sacrificed at week 33 (group A) and week 32 (group B). ( B ) Representative MRI images at week 33 (group A) of PLGA-PEI-si-NT- and PLGA-PEI-si-m/hVDAC1-B-treated mice. The arrows point to tumors. ( C ) Quantification of tumor volume from MRI images of group A at week 30 (PLGA-PEI-si-NT, n = 6, PLGA-PEI-si-m/hVDAC1-B, n = 7) and week 33 (PLGA-PEI-si-NT, n = 5, PLGA-PEI-si-m/hVDAC1-B, n = 5) and for group B at week 32 (PLGA-PEI-si-NT, n = 3, PLGA-PEI-si-m/hVDAC1-B, n = 4). ( D ) IF staining of VDAC1 in lung sections from PLGA-PEI-si-m/hVDAC1-B and PLGA-PEI-si-NT-treated mice. The squares point to the area enlarged below. ( E , F ) IHC staining for KI-67 using specific antibodies of PLGA-PEI-si-NT- and PLGA-PEI-si-m/hVDAC1-B-treated mice ( E ). For the sections, the lungs with tumors are shown with enlarged area below. KI-67 staining intensity was analyzed quantitatively (n = 7) ( F ). Results present the mean ± SEM, * p ≤ 0.05, *** p ≤ 0.001.

Article Snippet: Bovine serum albumin (BSA), poly (D, L-lactic-co-glycolic acid) (PLGA), polyethylenimine (PEI), polyvinyl alcohol (PVA), trypan blue, Triton X-100, Tween-20, hematoxylin, eosin, 4′,6-diamidino-2-phenylindole (DAPI), dimethyl sulfoxide (DMSO), and urethane were obtained from Sigma-Aldrich (St. Louis, MO, USA).

Techniques: Expressing, Injection, Imaging, Staining, Immunohistochemistry

PLGA-PEI-si-m/hVDAC1-B treatment reduced expression of energy- and metabolism-related proteins. Representative IHC staining of lung sections of PLGA-PEI-si-m/hVDAC1-B- and PLGA-PEI-si-NT-treated mice using specific antibodies against Glut 1 ( A , B ), HK-I ( C , D ) and VDAC1 ( E , F ), shown in two different magnifications. Staining intensity was quantified as described in the Methods section. Results present the mean ± SEM (n = 5), * p ≤ 0.05.

Journal: Cancers

Article Title: Mitochondrial VDAC1 Silencing in Urethane-Induced Lung Cancer Inhibits Tumor Growth and Alters Cancer Oncogenic Properties

doi: 10.3390/cancers16172970

Figure Lengend Snippet: PLGA-PEI-si-m/hVDAC1-B treatment reduced expression of energy- and metabolism-related proteins. Representative IHC staining of lung sections of PLGA-PEI-si-m/hVDAC1-B- and PLGA-PEI-si-NT-treated mice using specific antibodies against Glut 1 ( A , B ), HK-I ( C , D ) and VDAC1 ( E , F ), shown in two different magnifications. Staining intensity was quantified as described in the Methods section. Results present the mean ± SEM (n = 5), * p ≤ 0.05.

Article Snippet: Bovine serum albumin (BSA), poly (D, L-lactic-co-glycolic acid) (PLGA), polyethylenimine (PEI), polyvinyl alcohol (PVA), trypan blue, Triton X-100, Tween-20, hematoxylin, eosin, 4′,6-diamidino-2-phenylindole (DAPI), dimethyl sulfoxide (DMSO), and urethane were obtained from Sigma-Aldrich (St. Louis, MO, USA).

Techniques: Expressing, Immunohistochemistry, Staining

Effect of PLGA-PEI-si-m/hVDAC1-B treatment on the expression of CSC-related markers. ( A , B ) Representative lung sections IHC stained with specific antibodies against SOX2 ( A ) and ALDHA1 ( B ), showing enlarged areas from tumor-free and tumor tissues. ( C , D ) Representative IHC staining of stem cell markers CD44 and CD1133 in PLGA-PEI-si-NT- and PLGA-PEI-si-m/hVDAC1-B-treated mice ( C ) and their quantified staining intensity ( D ). Results reflect the mean ± SEM (n = 3), ** p ≤ 0.01, *** p ≤ 0.001.

Journal: Cancers

Article Title: Mitochondrial VDAC1 Silencing in Urethane-Induced Lung Cancer Inhibits Tumor Growth and Alters Cancer Oncogenic Properties

doi: 10.3390/cancers16172970

Figure Lengend Snippet: Effect of PLGA-PEI-si-m/hVDAC1-B treatment on the expression of CSC-related markers. ( A , B ) Representative lung sections IHC stained with specific antibodies against SOX2 ( A ) and ALDHA1 ( B ), showing enlarged areas from tumor-free and tumor tissues. ( C , D ) Representative IHC staining of stem cell markers CD44 and CD1133 in PLGA-PEI-si-NT- and PLGA-PEI-si-m/hVDAC1-B-treated mice ( C ) and their quantified staining intensity ( D ). Results reflect the mean ± SEM (n = 3), ** p ≤ 0.01, *** p ≤ 0.001.

Article Snippet: Bovine serum albumin (BSA), poly (D, L-lactic-co-glycolic acid) (PLGA), polyethylenimine (PEI), polyvinyl alcohol (PVA), trypan blue, Triton X-100, Tween-20, hematoxylin, eosin, 4′,6-diamidino-2-phenylindole (DAPI), dimethyl sulfoxide (DMSO), and urethane were obtained from Sigma-Aldrich (St. Louis, MO, USA).

Techniques: Expressing, Staining, Immunohistochemistry

Urethane treatment of A/J mice may induce both small and non-small lung cancer. ( A ) Representative H&E staining of formaldehyde-fixed paraffin-embedded sections from A/J mice lungs treated with PLGA-PEI-si-NT, showing two different morphologies as visualized in images at three different magnifications. ( B , C ) Representative lung sections of PLGA-PEI-si-NT-treated mice, IHC stained using specific antibodies against KI-67 ( B ) and synaptophysin ( C ), known to be highly expressed in SCLC. The squares show the areas from the high and low IHC-stained tumors that were magnified 25-fold in the images shown on the right. ( D ) Quantitative analysis of the indicated proteins’ staining intensities. Results reflect the mean ± SEM (n = 3), **** p ≤ 0.0001.

Journal: Cancers

Article Title: Mitochondrial VDAC1 Silencing in Urethane-Induced Lung Cancer Inhibits Tumor Growth and Alters Cancer Oncogenic Properties

doi: 10.3390/cancers16172970

Figure Lengend Snippet: Urethane treatment of A/J mice may induce both small and non-small lung cancer. ( A ) Representative H&E staining of formaldehyde-fixed paraffin-embedded sections from A/J mice lungs treated with PLGA-PEI-si-NT, showing two different morphologies as visualized in images at three different magnifications. ( B , C ) Representative lung sections of PLGA-PEI-si-NT-treated mice, IHC stained using specific antibodies against KI-67 ( B ) and synaptophysin ( C ), known to be highly expressed in SCLC. The squares show the areas from the high and low IHC-stained tumors that were magnified 25-fold in the images shown on the right. ( D ) Quantitative analysis of the indicated proteins’ staining intensities. Results reflect the mean ± SEM (n = 3), **** p ≤ 0.0001.

Article Snippet: Bovine serum albumin (BSA), poly (D, L-lactic-co-glycolic acid) (PLGA), polyethylenimine (PEI), polyvinyl alcohol (PVA), trypan blue, Triton X-100, Tween-20, hematoxylin, eosin, 4′,6-diamidino-2-phenylindole (DAPI), dimethyl sulfoxide (DMSO), and urethane were obtained from Sigma-Aldrich (St. Louis, MO, USA).

Techniques: Staining